| 3051 | 3-[2-[[(2-Methoxyphenyl)methyl]amino]ethyl]-2,4(1h,3 h)-quinazolinedione3-(2-((2-Methoxybenzyl)amino)ethyl)quinazoline-2,4(1H,3H)-dione, 3-[2-[[(2-Methoxyphenyl)methyl]amino]ethyl]-2,4(1H,3H)-quinazolinedione (RH-34), 3-{2-[(2-Methoxybenzyl)amino]ethyl}-2,4(1H,3H)-quinazolinedione, Methoxyphenyl)methyl]amino]ethyl]-2,4(1H,3H)quinazolinedione | | Pharmaceutical Affairs Law | Designated Substances | | Prohibition of manufacture and import of pharmaceutical products, non-pharmaceutical products and medical devices without a permit from Minister for Health, Labour and Welfare | Ministry of Health, Labour and Welfare | | Pharmaceutical Affairs Law |